POZEN, Inc.

POZEN, Inc.

POZEN, Inc.

Overview
Date Founded

1996

Headquarters

1122 Oberlin Road,Raleigh, NC 27605

Type of Company

Private

Industries

Pharmaceuticals

Company Description

POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC.

Contact Data
Trying to get in touch with decision makers at POZEN, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Business Officer

Chief Financial Officer, Senior Vice President-Finance & Administration

CAO, Vice President-Finance & Administration

Vice President FIG

Vice President Biostatistics

Board of Directors

Managing Director at GCA Corp. (Japan)

President & Chief Executive Officer at Impel NeuroPharma, Inc.

Paths to POZEN, Inc.
Potential Connections via
Relationship Science
You
POZEN, Inc.
Recent Transactions
Details Hidden

POZEN, Inc. purchases Aralez Pharmaceuticals Canada, Inc. resulting in a new company Aralez Pharmaceuticals, Inc.

Details Hidden

POZEN, Inc. issued USD Common Stock

Transaction Advisors
Legal Advisor

Advised onPOZEN, Inc. purchases Aralez Pharmaceuticals Canada, Inc. resulting in a new company Aralez Pharmaceuticals, Inc.

Selling Group Member

Advised onPOZEN, Inc. issued USD Common Stock

Selling Group Member

Advised onPOZEN, Inc. issued USD Common Stock

Legal Advisor

Advised onPOZEN, Inc. purchases Aralez Pharmaceuticals Canada, Inc. resulting in a new company Aralez Pharmaceuticals, Inc.

Co-Managing Partner

Advised onPOZEN, Inc. purchases Aralez Pharmaceuticals Canada, Inc. resulting in a new company Aralez Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Advisor

Founder at POZEN, Inc.

Advisor

Former Secretary, Senior Vice President & General Counsel at POZEN, Inc.

Investors
Details Hidden

Co-Founder & Vice Chairman of the Board at Aralez Pharmaceuticals, Inc.

Details Hidden

Canaan Management focuses on investments primarily in the technology and healthcare sectors. In the technology sector, the firm focuses on digital media, communications, mobility, enterprise software and clean technology. Within the healthcare sector, Canaan Partners focuses on investments in biopharmaceuticals, medical devices and diagnostics. Canaan Partners also invests technology-based Indian companies in the following sectors: consumer Internet, digital media, mobile and enterprise and managed services. In Israel, the firm seeks to invest in the development of early-stage companies in the following areas: (1) consumer Internet and digital media (2) communications infrastructure (3) enterprise software (4) clean technology and (5) medical device technologies.

Details Hidden

Bellevue AM is an active, fundamental research-based manager which utilizes a bottom-up investment and anti-cyclical approach, aiming to generate above-average returns while keeping risk under control and well monitored. They screen and invest in promising family and owner-managed companies based in Switzerland or the broader European continent through our family of Entrepreneur funds. The firm has become very adept at identifying high growth potential in new and emerging markets, particularly on the African continent. In addition to global equity and fixed income funds, Bellevue AM successfully manage multi-asset funds. A diverse family of ETF strategies (asset allocation with ETFs) rounds out the holistic profile. The firm’s in-house capital market research specialists systematically identify the most attractive asset classes, markets and sectors, as viewed from a holistic perspective. Their flagship investment vehicle, BB Biotech AG invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. BB Biotech’s investment portfolio usually consists of 20 up to a maximum of 35 biotechnology companies. There are established, large-cap companies as well as small- and mid-cap companies in the portfolio. The asset classes available to BB Biotech are direct investments in the shares of listed companies, equity interests in unlisted companies, corporate bonds, and options on a range of underlying assets. Bellevue AM invests almost exclusively in stocks for liquidity and risk/return reasons. At least 90% of its shareholdings must be in listed companies, while always holding more than 50% of its assets in equity investments. Corporate bonds are an alternative primarily when stock market trends are negative. Options on the stocks of portfolio companies will be bought and sold at opportune times and as a means of hedging currency exposure.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by POZEN, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of POZEN, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and POZEN, Inc..